Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging
- PMID: 34797013
- DOI: 10.1002/jmri.28003
Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging
Abstract
Background: The ovarian-adnexal reporting and data system-magnetic resonance imaging (O-RADS-MRI) score decreases the incidence of indeterminate adnexal masses from 18% to 31% with ultrasound till 10.8% to 12.5% with MRI. Further improvement of this score may be useful to improve patients' management.
Purpose: To evaluate the added value of quantitative diffusion-weighted imaging (DWI) in the diagnosis of adnexal masses classified according to the O-RADS-MRI score.
Study type: Prospective cohort study with retrospective DWI analysis.
Population: Among 402 recruited patients, surgery was done only in 163 women (median-age: 51 years) with 201 indeterminate adnexal masses, which were included in the final analysis.
Field strength/sequence: Standardized MRI (1.5 and 3-T) including diffusion and dynamic contrast-enhanced sequences (diffusion-weighted single-shot spin-echo echo-planar imaging) were used.
Assessment: Two radiologists classified the adnexal masses according to O-RADS-MRI and they were blinded to the pathology report. Two methods of quantitative analysis were applied using region-of-interest apparent-diffusion-coefficient (ROI-ADC) and whole-lesion ADC-histogram (WL-ADC).
Statistical tests: Fisher's exact and Mann-Whitney-U tests were used to compare variables among malignant and benign lesions. Receiver-operating-characteristic (ROC) curves were constructed to examine the sensitivity/specificity of each parameter. ROI-ADC and WL-ADC of lesions with O-RADS-MRI score-4 were plotted to identify thresholds of malignant lesions. The improvement of the O-RADS-MRI score after adding these thresholds was assessed by two ROC-curves. A P < 0.05 was considered to be statistically significant.
Results: Fifty-eight of the 201 lesions (28.9%) were malignant. The ROI-ADC and the WL-ADC means of malignant lesions were significantly lower than those of benign lesions. Forty-two lesions (20.9%) had an O-RADS-MRI score-4. In this subgroup, 76% of lesions with ROI-ADC < 1.7 × 10-3 mm2 /sec and WL-ADC < 2.6 × 10-3 mm2 /sec were malignant, whereas only 11.8% with ROI-ADC ≥ 1.7 × 10-3 mm2 /sec or a WL-ADC ≥ 2.6 × 10-3 mm2 /sec were malignant. The overall performance of the O-RADS-MRI score combined with these thresholds was improved.
Data conclusion: Integrating ADC-thresholds in O-RADS-MRI score-4 may discriminate low-to-intermediate and intermediate-to-high malignancy risk groups.
Level of evidence: 2 TECHNICAL EFFICACY STAGE: 2.
Keywords: adnexal diseases; apparent diffusion coefficient; diffusion magnetic resonance imaging; image interpretation; whole-lesion segmentation.
© 2021 International Society for Magnetic Resonance in Medicine.
Comment in
-
Editorial for "Added-Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging (O-RADS MRI): A Prospective Cohort Study".J Magn Reson Imaging. 2022 Jul;56(1):171-172. doi: 10.1002/jmri.28011. Epub 2021 Dec 6. J Magn Reson Imaging. 2022. PMID: 34866277 No abstract available.
Similar articles
-
How to improve O-RADS MRI score for rating adnexal masses with cystic component?Eur Radiol. 2022 Sep;32(9):5943-5953. doi: 10.1007/s00330-022-08644-3. Epub 2022 Mar 24. Eur Radiol. 2022. PMID: 35332409
-
Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map.Ultrasound Obstet Gynecol. 2021 Mar;57(3):478-487. doi: 10.1002/uog.22090. Ultrasound Obstet Gynecol. 2021. PMID: 32438461
-
Quantitative diffusion weighted imaging (DWI) improves the diagnostic accuracy of the O-RADS MRI scoring system in indeterminate adnexal lesions.Radiologia (Engl Ed). 2025 May-Jun;67(3):309-318. doi: 10.1016/j.rxeng.2024.01.005. Epub 2025 Jan 11. Radiologia (Engl Ed). 2025. PMID: 40412844
-
O-RADS MRI SCORE: An Essential First-Step Tool for the Characterization of Adnexal Masses.J Magn Reson Imaging. 2024 Mar;59(3):720-736. doi: 10.1002/jmri.28947. Epub 2023 Aug 7. J Magn Reson Imaging. 2024. PMID: 37550825 Review.
-
O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.Radiology. 2023 Apr;307(1):e220795. doi: 10.1148/radiol.220795. Epub 2022 Nov 22. Radiology. 2023. PMID: 36413127
Cited by
-
MRI Improves the Characterization of Incidental Adnexal Masses Detected at Sonography.Radiology. 2023 Apr;307(1):e222866. doi: 10.1148/radiol.222866. Epub 2022 Nov 22. Radiology. 2023. PMID: 36413134 Free PMC article. No abstract available.
-
Clinical value of quantitative analysis of contrast-enhanced ultrasonography in the differential diagnosis of benign and malignant pelvic tumors.Quant Imaging Med Surg. 2023 Oct 1;13(10):6636-6645. doi: 10.21037/qims-23-582. Epub 2023 Aug 24. Quant Imaging Med Surg. 2023. PMID: 37869279 Free PMC article.
-
Impact of DWI and ADC values in Ovarian-Adnexal Reporting and Data System (O-RADS) MRI score.Radiol Med. 2023 May;128(5):565-577. doi: 10.1007/s11547-023-01628-3. Epub 2023 Apr 25. Radiol Med. 2023. PMID: 37097348 Free PMC article.
-
Diagnostic performance of the O-RADS MRI system for magnetic resonance imaging in discriminating benign and malignant adnexal lesions: a systematic review, meta-analysis, and meta-regression.Diagn Interv Radiol. 2025 Apr 28;31(3):171-179. doi: 10.4274/dir.2024.242784. Epub 2024 Jul 8. Diagn Interv Radiol. 2025. PMID: 38973658 Free PMC article.
-
MRI Evaluation and Characterization of Ovarian Lesions Based on Ovarian-Adnexal Reporting and Data System MRI.Cureus. 2024 Aug 27;16(8):e67904. doi: 10.7759/cureus.67904. eCollection 2024 Aug. Cureus. 2024. PMID: 39328653 Free PMC article.
References
-
- Callahan T, Caughey A. Blueprints obstetrics and gynecology. 7th ed. Pennsylvania: Lippincott Williams and Wilkins Philadelphia; 2018 1312p.
-
- Bentivegna E, Gouy S, Maulard A, et al. Fertility-sparing surgery in epithelial ovarian cancer: A systematic review of oncological issues. Ann Oncol 2016;27(11):1994-2004.
-
- Johansen G, Dahm-Kähler P, Staf C, Flöter Rådestad A, Rodriguez-Wallberg KA. A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women. BMC Cancer 2020;20(1):1009.
-
- Timmerman D, Van Calster B, Testa A, et al. Predicting the risk of malignancy in adnexal masses based on the simple rules from the international ovarian tumor analysis group. Am J Obstet Gynecol 2016;214:424-437.
-
- Meys EM, Kaijser J, Kruitwagen RF, et al. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis. Eur J Cancer 2016;58:17-29.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials